Trials / Completed
CompletedNCT01638455
Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples
Noninvasive Parameter Testing With Pulse CO-Oximetry and Measurement of Blood Constituents With In-Vitro Analyzers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,776 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.
Detailed description
Noninvasive readings from subjects done according to manufacturer's directions of use compared to simultaneously derived blood samples measured on in vitro analyzers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Noninvasive device | Noninvasive device |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2016-09-07
- Completion
- 2016-09-07
- First posted
- 2012-07-11
- Last updated
- 2017-05-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01638455. Inclusion in this directory is not an endorsement.